Mitochondria-targeted resveratrol derivatives act as cytotoxic pro-oxidants

Current Pharmaceutical Design

Volumn 20, Issue 2, 2014, Pages 172-179

  Sassi, Nicola ^a   Mattarei, Andrea ^a,b   Azzolini, Michele ^a   Bernardi, Paolo ^a,b   Szabo', Ildiko' ^a   Paradisi, Cristina ^a   Zoratti, Mario ^a,b   Biasutto, Lucia ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b CNR   (Italy)

Author keywords

Cancer; Mitocans; Mitochondria; Reactive oxygen species; Resveratrol

Indexed keywords

ANTINEOPLASTIC AGENT; CATALASE; CYTOSTATIC AGENT; CYTOTOXIC AGENT; HYDROGEN PEROXIDE; HYDROXYL GROUP; PROTEIN BAX; REACTIVE OXYGEN METABOLITE; RESVERATROL; SUPEROXIDE DISMUTASE;

ACETYLATION; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOOXIDATION; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; DEPOLARIZATION; METHYLATION; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; CELL DEATH; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE KNOCKOUT TECHNIQUES; HYDROGEN PEROXIDE; MICE; MITOCHONDRIA; NECROSIS; OXIDANTS; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; STILBENES;

EID: 84892984865     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/13816128113199990034     Document Type: Article

References (61)

1. Calì T, Ottolini D, Brini M. Mitochondrial Ca(2+) as a key regulator of mitochondrial activities. Adv Exp Med Biol 2012; 942: 53-73.
2. Orrenius S. Reactive oxygen species in mitochondria-mediated cell death. Drug Metab Rev 2007; 39: 443-55.
3. Nunnari J, Suomalainen A. Mitochondria: in sickness and in health. Cell 2012; 148: 1145-59.
4. Murphy MP. How mitochondria produce reactive oxygen species. Biochem J 2009; 417: 1-13.
5. Biasutto L, Szabo' I, Zoratti M. Mitochondrial effects of plantmade compounds. Antioxid Redox Signal 2011; 15: 3039-59.
6. Ziech D, Franco R, Pappa A, Panayiotidis MI. Reactive oxygen species (ROS)--induced genetic and epigenetic alterations in human carcinogenesis. Mutat Res 2011; 711: 167-73.
7. Pani G, Giannoni E, Galeotti T, Chiarugi P. Redox-based escape mechanism from death: the cancer lesson. Antioxid Redox Signal 2009; 11: 2791-806.
8. Ishikawa K, Takenaga K, Akimoto M, et al. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 2008; 320: 661-4.
9. Patten DA, Lafleur VN, Robitaille GA, Chan DA, Giaccia AJ, Richard DE. Hypoxia-inducible factor-1 activation in nonhypoxic conditions: the essential role of mitochondrial-derived reactive oxygen species. Mol Biol Cell 2010; 21: 3247-57.
10. Verschoor ML, Wilson LA, Singh G. Mechanisms associated with mitochondrial-generated reactive oxygen species in cancer. Can J Physiol Pharmacol 2010; 88: 204-19.
11. Ueda S, Masutani H, Nakamura H, Tanaka T, Ueno M, Yodoi J. Redox control of cell death. Antioxid Redox Signal 2002; 4: 405-14.
12. Takeda K, Naguro I, Nishitoh H, Matsuzawa A, Ichijo H. Apoptosis signaling kinases: from stress response to health outcomes. Antioxid Redox Signal 2011; 15: 719-61.
13. Orrenius S, Zhivotovsky B. Cardiolipin oxidation sets cytochrome c free. Nat Chem Biol 2005; 1: 188-9.
14. Rasola A, Bernardi P. Mitochondrial permeability transition in Ca(2+)-dependent apoptosis and necrosis. Cell Calcium 2011; 50: 222-33.
15. Halestrap AP. Mitochondria and reperfusion injury of the heart--a holey death but not beyond salvation. J Bioenerg Biomembr 2009; 41: 113-21.
16. Di Lisa F, Bernardi P. Mitochondria and ischemia-reperfusion injury of the heart: fixing a hole. Cardiovasc Res 2006; 70: 191-9.
17. Smith RA, Hartley RC, Cochemé HM, Murphy MP. Mitochondrial pharmacology. Trends Pharmacol Sci 2012; 33: 341-52.
18. Biasutto L, Dong LF, Zoratti M, Neuzil J. Mitochondrially targeted anti-cancer agents. Mitochondrion 2010; 10: 670-81. Erratum in: Mitochondrion 2011; 11: 996.
19. Murphy MP. Targeting lipophilic cations to mitochondria. Biochim Biophys Acta 2008; 1777: 1028-31.
20. Chen LB. Mitochondrial membrane potential in living cells. Annu Rev Cell Biol 1988; 4: 155-81.
21. Bonnet S, Archer SL, Allalunis-Turner J, et al. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 2007; 11: 37-51.
22. Modica-Napolitano JS, Aprille JR. Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells. Adv Drug Deliv Rev 2001; 49: 63-70.
23. Heerdt BG, Houston MA, Augenlicht LH. The intrinsic mitochondrial membrane potential of colonic carcinoma cells is linked to the probability of tumor progression. Cancer Res 2005; 65: 9861-7.
24. Mattarei A, Biasutto L, Marotta E, et al. A mitochondriotropic derivative of quercetin: a strategy to increase the effectiveness of polyphenols. Chembiochem 2008; 9: 2633-42.
25. Biasutto L, Mattarei A, Marotta E, et al. Development of mitochondria-targeted derivatives of resveratrol. Bioorg Med Chem Lett 2008; 18: 5594-7.
26. Lin X, Wu G, Huo WQ, Zhang Y, Jin FS. Resveratrol induces apoptosis associated with mitochondrial dysfunction in bladder carcinoma cells. Int J Urol 2012; 19: 757-64.
27. Delmas D, Solary E, Latruffe N. Resveratrol, a phytochemical inducer of multiple cell death pathways: apoptosis, autophagy and mitotic catastrophe. Curr Med Chem 2011; 18: 1100-21.
28. Zhang W, Wang X, Chen T. Resveratrol induces mitochondriamediated AIF and to a lesser extent caspase-9-dependent apoptosis in human lung adenocarcinoma ASTC-a-1 cells. Mol Cell Biochem 2011; 354: 29-37.
29. Low IC, Chen ZX, Pervaiz S. Bcl-2 modulates resveratrol-induced ROS production by regulating mitochondrial respiration in tumor cells. Antioxid Redox Signal 2010; 13: 807-19.
30. Ungvari Z, Sonntag WE, de Cabo R, Baur JA, Csiszar A. Mitochondrial protection by resveratrol. Exerc Sport Sci Rev 2011; 39: 128-32.
31. Wang XX, Li YB, Yao HJ, et al. The use of mitochondrial targeting resveratrol liposomes modified with a dequalinium polyethylene glycol-distearoylphosphatidyl ethanolamine conjugate to induce apoptosis in resistant lung cancer cells. Biomaterials 2011; 32: 5673-87.
32. Sassi N, Biasutto L, Mattarei A, et al. Cytotoxicity of a mitochondriotropic quercetin derivative: Mechanisms. Biochim Biophys Acta 2012; 1817: 1095-106.
33. Mattarei A, Sassi N, Durante C, et al. Redox properties and cytotoxicity of synthetic isomeric mitochondriotropic derivatives of the natural polyphenol quercetin. Eu J Organic Chem 2011; 28: 5577-86.
34. Salvi A, Carrupt PA, Mayer JM, Testa B. Esterase-like activity of human serum albumin toward prodrug esters of nicotinic acid. Drug Metab Dispos 1997; 25: 395-8.
35. Walle T. Bioavailability of resveratrol. Ann N Y Acad Sci 2011; 1215: 9-15.
36. Wenzel E, Somoza V. Metabolism and bioavailability of transresveratrol. Mol Nutr Food Res 2005; 49: 472-81.
37. Doughan AK, Dikalov SI. Mitochondrial redox cycling of mitoquinone leads to superoxide production and cellular apoptosis. Antioxid Redox Signal 2007; 9: 1825-36.
38. Antonenko YN, Avetisyan AV, Bakeeva LE, et al. Mitochondriatargeted plastoquinone derivatives as tools to interrupt execution of the aging program. 1. Cationic plastoquinone derivatives: synthesis and in vitro studies. Biochemistry (Mosc) 2008; 73: 1273-87.
39. Dong LF, Jameson VJ, Tilly D, et al. Mitochondrial targeting of vitamin E succinate enhances its pro-apoptotic and anti-cancer activity via mitochondrial complex II. J Biol Chem 2011; 286: 3717-28.
40. Neuzil J, Dong LF, Rohlena J, Truksa J, Ralph SJ. Classification of mitocans, anti-cancer drugs acting on mitochondria. Mitochondrion 2012; in press. DOI: 10. 1016/j. mito. 2012. 07. 112.
41. Zini R, Morin C, Bertelli A, Bertelli AA, Tillement JP. Effects of resveratrol on the rat brain respiratory chain. Drugs Exp Clin Res 1999; 25: 87-97.
42. D'Autréaux B, Toledano MB. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nature Rev Mol Cell Biol 2007; 8: 813-24.
43. Gough DR, Cotter TG. Hydrogen peroxide: a Jekyll and Hyde signalling molecule. Cell Death Dis 2011; 2: e213.
44. Rigoulet M, Yoboue ED, Devin A. Mitochondrial ROS generation and its regulation: mechanisms involved in H(2)O(2) signaling. Antioxid Redox Signal 2011; 14: 459-68.
45. Groeger G, Quiney C, Cotter TG. Hydrogen peroxide as a cellsurvival signaling molecule. Antioxid Redox Signal 2009; 11: 2655-71.
46. Gius D, Spitz DR. Redox signaling in cancer biology. Antioxid Redox Signal 2006; 8: 1249-52.
47. Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 2009; 8: 579-91.
48. Ralph SJ, Rodríguez-Enríquez S, Neuzil J, Saavedra E, Moreno-Sánchez R. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation-why mitochondria are targets for cancer therapy. Mol Aspects Med 2010; 31: 145-70.
49. Ralph SJ, Rodríguez-Enríquez S, Neuzil J, Moreno-Sánchez R. Bioenergetic pathways in tumor mitochondria as targets for cancer therapy and the importance of the ROS-induced apoptotic trigger. Mol Aspects Med 2010; 31: 29-59.
50. Shi X, Zhang Y, Zheng J, Pan J. Reactive oxygen species in cancer stem cells. Antioxid Redox Signal 2012; 16: 1215-28.
51. Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 2010; 48: 749-62.
52. Festjens N, Vanden Berghe T, Vandenabeele P. Necrosis, a wellorchestrated form of cell demise: signalling cascades, important mediators and concomitant immune response. Biochim Biophys Acta 2006; 1757: 1371-87.
53. Vanlangenakker N, Vanden Berghe T, Krysko DV, Festjens N, Vandenabeele P. Molecular mechanisms and pathophysiology of necrotic cell death. Curr Mol Med 2008; 8: 207-20.
54. Galluzzi L, Vitale I, Abrams JM, et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 2012; 19: 107-20.
55. Wondrak GT. Redox-directed cancer therapeutics: molecular mechanisms and opportunities. Antioxid Redox Signal 2009; 11: 3013-69.
56. Biasutto L, Sassi N, Mattarei A, et al. Impact of mitochondriotropic quercetin derivatives on mitochondria. Biochim Biophys Acta 2010; 1797: 189-96.
57. López-Nicolás JM, García-Carmona F. Aggregation state and pKa values of (E)-resveratrol as determined by fluorescence spectroscopy and UV-visible absorption. J Agric Food Chem 2008; 56: 7600-5.
58. Zoratti M, Szabò I, De Marchi U. Mitochondrial permeability transitions: how many doors to the house? Biochim Biophys Acta 2005; 1706: 40-52.
59. Basso E, Petronilli V, Forte MA, Bernardi P. Phosphate is essential for inhibition of the mitochondrial permeability transition pore by cyclosporin A and by cyclophilin D ablation. J Biol Chem 2008; 283: 26307-11.
60. Scorrano L, Nicolli A, Basso E, Petronilli V, Bernardi P. Two modes of activation of the permeability transition pore: the role of mitochondrial cyclophilin. Mol Cell Biochem 1997; 174: 181-4.
61. Li B, Chauvin C, De Paulis D, et al. Inhibition of complex I regulates the mitochondrial permeability transition through a phosphate-sensitive inhibitory site masked by cyclophilin D. Biochim Biophys Acta 2012; 1817: 1628-34.